We are live on ! Find out more
TDOC icon

Teladoc Health

426 hedge funds and large institutions have $1.97B invested in Teladoc Health in 2024 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 126 increasing their positions, 138 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $71.4M | Put options by funds: $69.5M

0% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 71

9% less repeat investments, than reductions

Existing positions increased: 126 | Existing positions reduced: 138

1.4% less ownership

Funds ownership: 79.53%78.13% (-1.4%)

2% less funds holding

Funds holding: 435426 (-9)

30% less capital invested

Capital invested by funds: $2.84B → $1.97B (-$863M)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
426
Holders Change
-9
Holders Change %
-2.07%
% of All Funds
6.14%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
71
Increased
126
Reduced
138
Closed
71
Calls
$71.4M
Puts
$69.5M
Net Calls
+$1.84M
Net Calls Change
-$108M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
226
Principal Financial Group
Iowa
$209K +$62.5K +3,442 +33%
EH
227
Equitable Holdings
New York
$208K -$24.8K -1,364 -9%
FAIM
228
Financial Advocates Investment Management
Washington
$204K -$54.2K -2,986 -18%
IP
229
Ignite Planners
California
$198K +$15.6K +857 +7%
AWM
230
Axxcess Wealth Management
California
$195K -$33.8K -1,861 -13%
SW
231
SteelPeak Wealth
California
$189K -$21.3K -1,173 -9%
Pathstone Holdings
232
Pathstone Holdings
New Jersey
$186K +$12K +662 +6%
LOAMU
233
Lombard Odier Asset Management (USA)
New York
$183K +$220K +12,137 New
EIP
234
Easterly Investment Partners
Massachusetts
$181K
ICP
235
Interchange Capital Partners
Pennsylvania
$180K -$17.7K -975 -8%
MFG
236
MidWestOne Financial Group
Iowa
$175K +$41.2K +2,272 +24%
NFSG
237
Newbridge Financial Services Group
Florida
$172K +$198K +10,889 +2,131%
MSRPS
238
Maryland State Retirement & Pension System
Maryland
$168K
Mariner
239
Mariner
Kansas
$167K +$201K +11,072 New
I
240
InceptionR
California
$163K +$195K +10,769 New
AB
241
Amalgamated Bank
New York
$140K -$250K -13,762 -60%
US Bancorp
242
US Bancorp
Minnesota
$129K -$77.6K -4,277 -33%
AWM
243
Avondale Wealth Management
Texas
$121K +$145K +8,000 New
William Blair & Company
244
William Blair & Company
Illinois
$120K -$196K -10,818 -58%
Russell Investments Group
245
Russell Investments Group
United Kingdom
$110K -$252K -13,890 -66%
Acadian Asset Management
246
Acadian Asset Management
Massachusetts
$100K +$120K +6,636 New
MA
247
Montag & Associates
Georgia
$86.9K
WIM
248
Westside Investment Management
California
$85.4K +$28.1K +1,550 +38%
AF
249
Advisornet Financial
Minnesota
$77.8K +$1.52K +84 +2%
Carson Wealth (CWM LLC)
250
Carson Wealth (CWM LLC)
Nebraska
$71K -$13.5K -742 -14%

TDOC Hedge Fund Activity: Q1 2024 in Review

426 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q1 2024, worth a combined $1.97B — down 30% from $2.84B a quarter earlier.

Fund positioning in TDOC was balanced in Q1 2024: 71 funds opened new positions, 71 closed out, 126 added to existing stakes and 138 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $28.6M. The largest seller was ARK Investment Management, cutting an estimated $94.2M.

  • 426 institutional investors held Teladoc Health (TDOC) as of Q1 2024, down from 435 in Q4 2023.
  • Funds reported $1.97B of Teladoc Health stock for Q1 2024, down 30% quarter-over-quarter.
  • 71 funds opened new Teladoc Health positions in Q1 2024 and 71 closed out, a net change of 0 holders.
  • The largest Teladoc Health buyer in Q1 2024 was Two Sigma Advisers, an estimated $28.6M added.
  • The largest Teladoc Health seller in Q1 2024 was ARK Investment Management, an estimated $94.2M sold.

Based on aggregated 13F filings for Q1 2024.